Industry Analysis Reports | Health Care | Medical Devices

Thursday 29 October 2020

Retinal Implants Market 2018 – Leading Manufactures, Regions, Drivers, Analysis and Forecasts Till 2025

Retinal implants have proven its mettle as a breakthrough therapy in the treatment of visual impairment. The global retinal implants market is perceived to be growing at a recurring rate and is expected to reach high revenue figures in the coming years, as per the analysis of Market Research Future (MRFR). The global retinal implant market has been flourishing on account of the widespread prevalence of eye disorders across the globe. Growing cases of retinal disorders have induced high demand for retinal implants since they aid in the restoration of vision. Retinal implants have demonstrated significance for application in eye disorders which were once far-off impossible to achieve. The fact that these devices can be implanted with minimally invasive procedures has added to its popularity and driven the market. The rise in geriatric population is a crucial factor driving the growth of the retinal implant market. Owing to various health insufficiencies, the aging population is more susceptible to acquiring visual impairment and require retinal implant.

Request Free Sample @https://www.marketresearchfuture.com/sample_request/6580

Substantial investment in R&D activities by various medical device manufacturers and governments have led to the development of advanced retinal implants which can be successfully implanted in patients. Extensive clinical trial activities have also contributed to the growth of the market. Few retinal implants have already cleared clinical trials, and many more are underway which is expected to spur the market in the future. In addition, the rise in a number of FDA approvals has been a plus for the growth of the global retinal implants market.

A large number of retinal implants are due for approval and patent from various regulatory authorities, the market stores opportunities for expansion. Also, expected expansion in reimbursement coverage for retinal implants is also expected to augment the market in the coming years. Other driving factors include the rise in the prevalence of degenerative diseases and raising awareness regarding the availability of the device which raises adoption. However, lack of skilled medical professionals with adequate knowledge of performing surgery and stringent and complex FDA approval process remains a significant hurdle for the growth of the global retinal implants market. High costs associated with retinal implants, the risk of biocompatibility and unknown long-term efficacy of the product are also expected to hinder adoption.

Segmentation

The global retinal implants market has been segmented into device type, disease indication, and end user. By device type, the market has been segmented into retina implant alpha AMS, Argus II, implantable miniature telescope, and others. By disease indication, the market has been segmented into age-related macular degeneration (AMD) and retinitis pigmentosa. By end user, the market has been segmented into multi-specialty hospitals, ophthalmic clinics, and research institutes.

Access Report @ https://www.marketresearchfuture.com/reports/retinal-implants-market-6580

Regional Analysis

North America, Europe, Asia Pacific, and the Rest of the World are the key markets for retinal implants. North America accounts for a substantial share of the global market. Higher availability of the product, improving reimbursement scenario and higher affordability in the region supports the growth of the North America market for retinal implants. Presence of highly skilled surgeons to perform immensely complex surgical procedure also accelerates adoption in the region.

In Europe, the market is driven by an increase in R&D activities and the expansion of clinical trials.

Presence of developing countries such as India, China, and Japan, who outlay massive amounts on healthcare expenditure, coupled with growing disposable income and affordability supports the growth of the market in Asia Pacific.

Rest of the World market is expected to fare well in the coming years since various market players are foraying into the untapped regions to leverage the potential they offer for market expansion.

Competitive Landscape

Second Sight Medical Products, Inc.; Retina Implant AG, VisionCare, Inc., Bionic Vision Australia (BVA), Bionic Eye Technologies, Inc., and Visus Technology, Inc. are the key players operating in the global retinal implants market.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Spirometry market News, Trends, Demand and Forecast

Overview:

The global Spirometry market is witnessing a significant rise in its revenues, mainly due to the rising occurrences of respiratory diseases such as asthma and COPD. Besides, the growing rate of diagnosis processes conducted for the detection of interstitial pulmonary fibrosis fosters the growth of the market. Moreover, the increasing exposure to risk factors and the ever-increasing population is driving a large share of the market.

According to Market Research Future (MRFR), the global Spirometry market is expected to garner a valuation of USD 1,106.76 MN by 2023, registering 10.03% CAGR over the assessment period (2018-2023). Factors such as the increasing healthcare expenditures and technological advances in respiratory care devices are estimated to support market growth over the forecast period.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/6539

Drivers & Restraints:

Spirometry is a medical test to evaluate lung functions vital for detecting asthma, COPD, and other breathing disorders. Spirometry is also performed for therapeutic reasons for asthma, chronic obstructive pulmonary disease, and restrictive lung disease. Growing exposure to risk factors, including smoking and pollutants such as chemicals, fumes, and dust, is fostering the growth of the market, increasing the prevalence of respiratory diseases.

On the other hand, factors such as the high cost of tests that require different spirometers and reimbursement limitations are inhibiting the growth of the market. Nevertheless, factors such as the growing government initiatives to spread the awareness and funding support to drive R&D required to improve diagnostics techniques and devices would support the growth of the market throughout the assessment period.

Global Spirometry Market – Segments

The analysis is segmented into five main dynamics to widen the scope of understanding,

By Product : Table-top Spirometry, Hand-held Spirometry, and Desktop (PC) Spirometry, and others.

By Technology : Flow Measurement Spirometry (Pneumotachograph System and Mass Flow Meter), Volume Measurement Spirometry, Peak Flow Meter (PFM), and others.

By Application : Diagnostic (Asthma, COPD, Interstitial Pulmonary Fibrosis, others), Treatment Monitoring, and others.

By End-user : Hospitals & Clinics, Research & Academic Institutes, Diagnostic Centers, Home Care, and others.

By Regions : Americas, Europe, Asia-Pacific, Middle East & Africa, and Rest-of-the-World.

Global Spirometry Market – Regional Analysis

North America dominates the global Spirometry market with the growing prevalence of respiratory diseases such as asthma, COPD, interstitial pulmonary fibrosis, and others. Besides, the huge technological advancements and rising adoption of Spirometry devices for improved diagnosis processes drive the regional market growth. Also, factors such as the availability of state-of-the-art facilities & infrastructure and growing awareness are fostering the demand in the regional market.

Additionally, the presence of large payers, high healthcare expenditures, and expanding rebate on diagnostics is further promoting the growth of the regional market. The North American Spirometry market is estimated to create a valuation of USD 444.99 MN by 2023, registering 10.25% CAGR during the forecast period.

Europe stands second in the spirometry market, growing rapidly. Factors such as the presence of large medical device companies in Germany and increasing healthcare expenses substantiate the growth of the regional market. Moreover, the proliferating healthcare industry and developed infrastructure in the region are major factors that are driving the market growth further. The European spirometry market valuation is expected to climb up to USD 322.33 MN by 2023, posting 10.25% CAGR throughout the review period.

The Asia Pacific Spirometry market has been witnessing significant growth, demonstrating the tremendous potential for future growth. Low diagnostic costs and large unmet clinical needs for respiratory diseases in the region provide ample opportunities for market growth. The valuation of the APAC Spirometry market is estimated to reach USD 247.52 MN by 2023, registering 10.64% CAGR during 2018-2023.

Global Spirometry Market – Competitive Landscape

Highly competitive, the Spirometry market appears to be fragmented due to the presence of several well-established players. There is a definite shift towards the hospital testing department, which dominates a large market share. As a result, players rely on their collaborations and partnerships with hospitals to increase market penetration of their products. Besides, these players employ numerous distributions channels and engage healthcare payers such as insurance companies to enhance their competitive share.

Major Players:

Players leading the global Spirometry market include NDD Medical Technologies, Inc. (US), Carefusion Corporation (US), Nihon Kohden Corporation (Germany), Vitalograph (UK), MGC Diagnostics Corporation (US), Schiller AG (Switzerland), Hill-Rom Holdings, Inc. (US), COSMED Srl. (Italy), Midmark Corporation (US), Koninklijke Philips N.V. (Netherlands), and Smiths Medical Inc. (US), among others.

Industry/ Innovation/ Related News:

December 04, 2019 ---- VivaLNK Connected Health Solutions (the US), a leading global provider of wearable medical solutions for continuous patient monitoring, announced scoring a CE mark for its multi-vital medical wearable sensor, SDK. VivaLNK mentioned that it had landed a Class IIa medical device CE Mark for its multi-vital medical wearable sensor & software development kit. The new technology allows researchers & clinicians to continuously stream a patient’s respiratory rate, ECG rhythm, heart rate, and RR interval & three-axis acceleration.

The company also mentioned that it has recently signed a deal with Current Health (the UK), a leading healthcare technology company for the distribution of VivaLNK that offers axillary temperature and spirometry measurements capabilities sighting on the European market. The company also claims that its sensors have been integrated into clinical trial monitoring and heart failure detection as well.

Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various

industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw

Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting

Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence

services to our clients. Our market research studies by products, services, technologies, applications,

end users, and market players for global, regional, and country level market segments, enable our

clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans &

conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

News: Type 2 diabetes mellitus treatment market 2020 | Trends | Analysis - MRFR

The Global Type 2 Diabetes Mellitus Market is expected to exhibit an upswing and capture a CAGR of 8% over the forecast period of 2017-2023, proclaims Market Research Future (MRFR) in an exhaustive research report. The global market is expanding at a rapid pace due to the increasing burden of type 2 diabetes across the globe. Type 2 diabetes mellitus has been increasing exponentially, and the market has observed a high prevalence rate in both developed and developing countries due to multiple risk factors of diabetes and delayed diagnosis. Development of novel efficient therapies is expected to create a supportive dais for building up the global type 2 diabetes mellitus market. The inefficiency of current therapies and life-threatening complications arising out of type 2 diabetes mellitus has necessitated the development of appropriate preventive measures.

For Free Sample PDF Visit @https://www.marketresearchfuture.com/sample_request/5669

The government of various countries have initiated awareness programs and are investing heavily in research & development. Moreover, there has been a rise in the number of FDA approvals for new drugs which have also helped the market expand. Other driving factors include an increase in healthcare expenditure on a global scale and a rise in risk factors of type 2 diabetes mellitus. Conversely, the market growth might be hindered by lack of awareness, the high cost of treatment and diagnosis, complex regulatory framework for FDA approvals of therapies, and the side effects of available treatment options.

Segmentation

The global type 2 diabetes mellitus treatment market has been segmented based on treatment and end user. By treatment, the market has been segmented into drug and devices. The drug segment has been further segmented into Insulin, Sensitizers, Sglt-2, Alpha-Glycosidase Inhibitors, Others. The devices segment has been further segmented into Blood Glucose Monitoring, Insulin Delivery Devices. By end user, the market has been segmented into hospitals, clinics, diagnostic centers, drug stores, pharmacies, and others.

Regional Analysis

The global type 2 diabetes mellitus treatment market spans across the regions of the Americas, Europe, Asia Pacific, and the Middle East & Africa. The Americas account for the largest share of the global type 2 diabetes mellitus market owing to the presence of a huge patient pool, well-developed healthcare sector, and the presence of leading players in the region. Moreover, due to the rising burden of diabetes mellitus on the healthcare, various companies and governments are endeavoring towards improving diabetes care. Europe is the second largest market for type 2 diabetes mellitus market. Government grants for research & Development coupled with favorable reimbursement scenario drive the market in Europe. Throughout Europe, charges for diagnosis and treatment of type 2 diabetes mellitus are covered under health insurance, especially for pregnant women. Asia Pacific is poised to be the fastest growing market on account of an epidemic increase in diabetes occurrence in the region which induces high demand for treatment and diagnosis. Also, the market is expanding due to substantial investment in the healthcare sector by the governments in the region. The Middle East & Africa market accounts for the least share of the market due to low healthcare penetration and poor medical facilities, especially in the Africa region. The Middle East market is expected to exhibit considerable growth over the forecast period due to improving the healthcare sector in the region.

Competitive Landscape

The notable players operating in the global type 2 diabetes mellitus treatment market include Abbott Laboratories, Adocia, Amgen, Bayer AG, Dickinson and Company, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Pfizer, Sanofi, Takeda Pharmaceuticals, Acon Laboratories, Inc., Akros Pharma, AstraZeneca, Becton, Biocon, Daiichi Sankyo, Merck, Novartis & Co., Peptron, Roche Diagnostics Ltd., Sunpharma, and others.

About Market Research Future:

Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various

industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw

Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting

Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence

services to our clients. Our market research studies by products, services, technologies, applications,

end users, and market players for global, regional, and country level market segments, enable our

clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans &

conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Veterinary Pain Management Market -Size, share, 2020, Global Demand by 2027

Market Highlights:

Veterinary Pain Management Market is growing rapidly and pervasively mainly due to the spreading

awareness towards animal care. People are generally compassionate towards their pets, and they are

increasingly becoming aware of animal physiology and psychology and the pain they go through during

sickness, injuries, recoveries and after effects of the diseases. Besides, factors such as the increasing

number of pet owners and the strengthening bond between owners and their animal companions

escalate the market on the global heights.

Get Sample PDF @https://www.marketresearchfuture.com/sample_request/5961

Acknowledging the rapid expansions, the market perceives currently, Market Research Future

(MRFR) in its recently published study report asserts that the global Veterinary Pain Management Market is expected to register a CAGR of 6.46% during the assessment period of 2020 to 2027, to reach USD 4,582.8 Million by 2027.

Additional factors substantiating the market growth include the rising per capita income that is leading

to increasing the pet adoptions and the trend of nuclear families. Increased awareness concerning

animal cruelty is influencing people’s ideologies and knowledge about animals.

Moreover, developments in animal health medicines and vaccines, along with the increased medical

treatments are fostering the market growth of veterinary pain management market. Increased R&D

expenditure to bring innovations in the products, and development of better and effective veterinary

pharmaceuticals and vaccines, etc. are contributing to the market growth.

Improving economic conditions worldwide foster market growth, enabling access to the quality of life,

increasing consumers’ buying power, and availing cost-effective veterinary healthcare.

On the other hand, factors such as the lack of awareness and knowledge pertaining to the animal well-

being and the rising cost of pet care, etc. are expected to impede the market growth. Also,

unavailability of skilled doctors is a major restraint the market is confronting with. Nevertheless,

technological advancement, increasing number of ambulatory services coupled with the government

and public organizations initiatives like PETA, working towards animal rights and liberation are

expected to support market growth.

Veterinary Pain Management Market - Segmentations

Global Veterinary Pain Management Market, by Product

Medication
- NSAIDs
  - Meloxicam
  - Etodolac
  - Others
- Opioids
  - Morphine
  - Codeine
  - Fentanyl
  - Hydromorphone
  - Others
- Local Anesthetics
  - Lidocaine
  - Bupivacaine
  - Chloroprocaine
  - Others
- Αlpha 2-Adrenergic Agonists
  - Medetomidine
  - Xylazine
  - Sedatives
  - Muscle Relaxants
  - Others
- Route of Administration
  - Oral
  - Parenteral
  - Topical
Devices
- Laser Therapy Devices
- Electromagnetic Therapy Devices

Global Veterinary Pain Management Market, by Animal Type

Companion Animals
- Dogs
- Cats
- Horses
- Others
Livestock Animals
- Cattle
- Pigs
- Poultry
- Others

Global Veterinary Pain Management Market, by Application

Joint Pain
- Osteoarthritis
- Musculoskeletal Disorders
Postoperative Pain
Cancer
Others

Global Veterinary Pain Management Market, by Distribution Channel

Veterinary Hospitals & Clinics
Pharmacies
Online Pharmacies

Veterinary Pain Management Market - Geographical Analysis

The North American region accounts for the leading market for veterinary pain management majorly

due to the availability of a range of animal care products, emphasis on animal health, and stringent

government regulations. Also, technological innovations in the field of veterinary surgical

instruments are acting as a tailwind pushing up the market growth in the region.

Additional factors such as growing insurance coverage schemes are expected to push the growth of

the veterinary pain management market in the region. Moreover, the increasing number of pets and a

large patients’ pool, contribute to the growth of the regional market, demanding various treatment

procedures and surgeries.

Countries such as Canada and the US are focusing on exporting surgical equipment and surgical

suturing material across the world, which, in turn, is increasing the size of the market in this region.

Besides, the growing number of veterinary hospitals fuel market growth.

The Veterinary Pain Management Market in the European region stands the second position in terms

of the market size, owing to the increasing pet ownership fuelled by the tax benefits granted by the

government. Increase in animal diseases has led to an increasing number of surgeries and veterinary

healthcare organizations. European countries like Germany, France, and the U.K, backed by the

significant expenditures in the field of manufacturing of veterinary medical and surgical devices,

majorly contributes to the growth of the regional market.

The Asia Pacific region is emerging as a promising market for companion veterinary pain

management. China among other APAC dominates the regional market whereas, India accounts for

the fastest growing market, followed by Australia and Japan. Factors such as the presence of a large

patient’s pool, increasing awareness towards animal health, and the improving economy are few of

the driving forces pushing up the market in the region.

Veterinary Pain Management Market - Competitive Landscape

The fiercely competitive veterinary pain management market appears to be fragmented due to many

players forming a competitive landscape. Mergers & acquisitions, innovations, and Brand

reinforcement remain the popular trends for the market players. Acquisitions of local manufactures

by multinational companies are changing the market structure, increasing the profit of the company

by reducing the competition significantly.

Key Players:

Some of the players leading the market include Zoetis, Boehringer Ingelheim, Chanelle, Ceva Santé

Animale, Dechra Pharmaceuticals, Norbrook Laboratories, Merck Animal Health, Elanco, Assisi

Animal Health, Bayer, and Vetoquinol.

Industry/ Innovation/ Related News:

November 08, 2018 – Vetoquinol USA, a world-class developer of veterinarian-approved formulas for

large animal healthcare products, announced the launch of its rebranded product line - EQUISTRO®.

The rebranding includes new packaging for products and others. All EQUISTRO products are now

available in veterinary clinics and in retail stores that sell feed, farm supplies, horse tack, and equine

products. The rebranding strategy helps to expand the products available for performance horses

through Vetoquinol.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/veterinary-pain-management-market-5961

About Market Research Future:

Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various

industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw

Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting

Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence

services to our clients. Our market research studies by products, services, technologies, applications,

end users, and market players for global, regional, and country level market segments, enable our

clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans &

conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Wednesday 28 October 2020

Trends On Neurovascular Devices Market (2020-2023) | Size | Share | Key Trends and Forecast

Neurovascular devices are increasingly being used in for treating and management of neurovascular disorders such as arteriovenous malformations (AVMs) and brain aneurysm. As the global burden of neurovascular disorders continue to rise, the demand for their treatments gains further traction. Neurovascular disease are complex in nature and hence preference for minimally invasive procedures is higher. This, in turn, is driving the sales of neurovascular devices across the globe. Market Research Future (FRMR) is its latest report asserts that the Neurovascular Devices Market will grow at a healthy rate over the next couple of years.

Incessant product innovation, increased product marketing and favourable reimbursement policies are driving the global market for neurovascular devices. Other factors that are reflecting favourably on the market include expansion of the geriatric population, and advances in medical technology in the field of interventional neurology. Moreover, neurovascular devices are also used in treating patients suffering for ischemic stroke or haemorrhagic. It has been observed that neurovascular device assisted interventional procedures are replacing the traditional neurosurgeries. Owing the low risk of damaging surrounding tissues and minimal surgical trauma, interventional procedure are more favoured as compared to neurosurgery. At the same time, chances of infection is significantly when neurovascular device based treatment. On the other hand, inadequate number of hilly skilled neurologist, particularly in developing countries expected to have a negative impact on the growth of the market. High cost of neurovascular devices continue to limit their user base despite their increased efficiency.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/5544

Latest Industry Highlights:

Perflow Medical, a renowned medical devices manufacturing company based in Israel, which is primarily engaged in developing novel solution for neurovascular interventions. Has recently announced that the company successfully approved a $12 Mn funding from its investors. Reportedly, the funding syndicate in included two new international investors with the existing stakeholders.

Junkosha a US-based company has recently introduced a unique peelable heat shrink. The technology will reportedly enable access to intricate parts of the vascular system with minimal risk of damage to the surroundings.

Global Market for Neurovascular Devices – Segmental Analysis

MRFR in its report has offer comprehensive segmental analysis of the market based on therapeutic application, end-user and product. By therapeutic application, the market is bifurcated into ischemic strokes and hemorrhagic stroke. Based on end user, the market is segment into ambulatory surgical units and hospitals & clinics. By product type, the market is segmented into stenting systems, neurothrombectomy devices, cerebral balloon angioplasty, aneurysm coiling & embolization devices and support device.

Regional Overview

The Americas is expected to hold the dominant position in the global market for neurovascular devices. This is primarily attributed to the rising incidences of neurovascular disorders such as arteriovenous malformations (AVMs) and brain aneurysm across North and South America. In addition, presence of major players and rising healthcare spending among Americans is propelling the market in the region. Improved reimbursement scenario and rapid adoption of neurovascular devices in neurological centers across the region is also proving an impetus to the market. Asia Pacific and Europe are two other regions anticipated to present significant growth opportunities for market during the forecast period.

Global Market for Neurovascular Devices – Competitive Analysis

Leading companies operating in the global market for neurovascular devices include Medtronic, TERUMO CORPORATION, Merit Medical Systems, Inc., Penumbra, Inc., Evasc, Neuravi, Sensome, Delaware Corporation, Gynesonics, Stryker, Johnson & Johnson Services, Inc., Abbott, Medikit co., ltd., MicroPort Scientific Corporation, Rapid Medical, W. L. Gore & Associates, Inc., Blockade Medical, LLC., OxfordEndovascular, and Secant Group, LLC. A majority of these market participants are actively focusing on expanding market presence by engaging in merger & acquisition and reaching offshore distribution agreements with third party vendors.

About Market Research Future:

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

News: Healthcare CMO Market 2020 -Demand, Size, Share and Research, Global Demand by 2023

Market Scenario

The global healthcare CMO market is presumed to expand at 9.86 % CAGR during the forecast period (2017-2023) owing to the growing demand for medicine supplies, asserts Market Research Future (MRFR). Healthcare contract manufacturing is the outsourcing of the manufacturing process of drugs to contract manufacturing organizations. It serves other companies in pharmaceutical industries and medical devices to offer comprehensive services from drug development to drug manufacturing.

Drivers and Constraints Impacting the Market

Patent protection expiration of major drugs along with medical devices and competition and economics of trade and production to favor CMO is likely to foster the market growth during the assessment period. The market is likely to expand owing to the growing demand for medical devices and drugs due to the increasing population in the emerging economies. Moreover, with the increasing demand for generic drugs, the rising number of patent expiries, and huge pipeline of drugs, the global market for healthcare contract manufacturing is anticipated to augment in the coming years.

On the flip side, issues of control of third parties coupled with complexities associated with supply chain are considered to retard the market growth over the assessment period. Also, rising complexities in the clinical trials along with lack of in-house laboratory capacity are likely to impede the growth of the market.

Global Healthcare Contract Manufacturing Market: Segmental Analysis

The global healthcare contract manufacturing market has been segmented on the basis of service type, type, industry, and region.

By mode of type, the global healthcare contract manufacturing market has been segmented into non-sterile and sterile. Among these, the non-sterile contract manufacturing is estimated to hold the largest market share.

By mode of service type, the global healthcare contract manufacturing market has been segmented into medical device contract manufacturing services and pharmaceutical contract manufacturing services. Among these, the pharmaceutical contract manufacturing services are presumed to hold the largest market share.

By mode of industry, the global healthcare contract manufacturing market has been segmented into biopharmaceutical, medical device, and pharmaceutical. Among these, the segment for medical devices is presumed to hold the largest market share with 43.7 %.

Regional Insights

Geographically, the global healthcare contract manufacturing market span across America, Europe, Asia Pacific, and the Middle East and Africa.

Among all the regions, the American region is anticipated to dominate the global market due to the growing investment in the healthcare sector, focus on research institutions on updating technologies, and presence of strong economic conditions. American contract manufacturers have also upgraded their factories and manufacturing capabilities. With cost-efficient models and advanced manufacturing units, American contract manufacturers are making Asian companies run for their money.

The European region is considered to hold the second position in the global market owing to the presence of high health care spending, and growing support from the government. For instance, according to the Organization for Economic Co-operation and Development, the expenditure on healthcare in Germany in 2014 was EUR 321 billion. France recorded the second highest level with EUR 237 billion.

Asia Pacific is presumed to be the fastest growing market due to the presence of a large number of developing nations in this region, such as China and India. Such developing countries are encouraging the growth of healthcare contract manufacturing market.

Industry News

October 16, 2018: Piramal Enterprises Ltd. is weighing the sale of its contract pharmaceutical business in a potential deal worth $1 billion, citing unidentified people. Piramal Pharma Solutions offer services from drug discovery to development as well as commercial manufacturing, with operations in Europe, North America, and Asia. The company has sent out preliminary marketing materials to potential buyers.

Competitive Dashboard

The major players operating the global market are Boehringer Ingelheim, Benchmark Electronics, Catalant, Patheon, Vetter Pharma International, Hamilton Company, Aesica Pharmaceuticals, AbbVie, Grifols International, Flex Ltd, Lonza Ag, Forefront Medical Technologies, Sanmina Corporation, Evonik Industries, Mylan, S.A, Teva Pharmaceutical Industries, and others.

Industry Highlights And Forecasts to2023

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Diabetes Monitors Market Investigation by Application, Technology and Product Type

According to Market Research Future (MRFR), the global diabetes monitors market is estimated to grow at a CAGR of 8.3% from 2017 to 2023 (forecast period). The report presents an in-depth description of the present scenario, the economic condition and COVID-19 analysis of the overall industry.

Latest Free sample Copy With Covid19 Impact!! https://www.marketresearchfuture.com/sample_request/4781

Diabetes mellitus is a chronic condition caused by the inadequacy of insulin in the body. The condition induces either high blood glucose concentrations, called hyperglycemia, or low glucose levels, known as hypoglycemia. Monitoring glucose levels is expected to improve life expectancy by allowing hypoglycemia or hyperglycemia to be managed. The self-monitoring method is most commonly used to check blood glucose levels. The method involves collecting blood from a finger or other part of the body to be examined with the aid of test strips and a glucometer.

While the blood remains the most widely used sample, other biological fluids such as ocular fluid, sweat, breath, interstitial fluid, saliva, or urine can also be used as substitute samples for continuous non-invasive monitoring. Since a cure for diabetes has yet to be developed, managing this condition is the most effective way to control it. Glucose monitoring is used to improve treatment strategies and provide insight into the impact of diet, medication, and exercise on the patient.

Diabetes Monitors Market Dynamics

Rising prevalence of diabetes is the key factor driving the demand for diabetes monitors. According to the National Diabetes Statistics Report stated by the Centers for Disease Control and Prevention, 9.4% of the U.S. population, i.e., 30.3 million people, had diabetes in 2015. The rising prevalence of diabetes in low-and middle-income countries appears to be fuelled by the nutritional transition, rapid urbanization, and growing sedentary lifestyles indicated by a study published in the journal Pharmacoeconomics in 2015.

Certain factors such as increased technological innovations, massive support for diabetes diagnosis and treatment research, increased acceptance by regulators, and an increase in the global prevalence of obesity is also spurring market growth. As per the Fogarty International Center, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and two renowned Indian research agencies took the initiative to fund a collaborative diabetes research agenda in 2013.

However, strict reimbursement policies and high costs associated with diagnosing and treating diabetes can impede market growth over the forecast period. As per a research report published in the Journal of Diabetes Science and Technology in 2015, it has been found that only a few patients in Germany, i.e., < 2000, use continuous glucose monitors (CGM) due to high costs.

Diabetes Monitors Market Segmentation

The global market for diabetes monitors has been segmented based on sample, type, component, and end-users.

Based on the sample, the global market for diabetes monitors has been segmented into blood samples, sweat samples, urine samples, and others.

Based on type, the global market for diabetes monitors has been classified into point sample test based glucose monitors, continuous glucose monitors, and enzyme-free sensor-based glucose monitors. Continuous glucose monitors are further divided into disposable sensor-based CGM and re-usable sensor based CGM.

Based on components, the global diabetes monitors Market has been segmented into lancet, glucose test strips, and sensors. Sensors are further divided into enzyme-based sensors and enzyme-free sensors

Based on end-users, the global market for diabetes monitors has been segmented into diagnostic clinics, hospitals, and homes.

Regional Analysis

APAC or Asia Pacific, the Americas, along with the Middle East and Africa/MEA and Europe are the top markets for diabetes monitors.

MRFR confirms that the American market is in the lead and has the potential to touch USD 6623.4 million by the year 2023. Europe has secured the second spot while APAC is slated to obtain the fastest growth rate of 8.9% from 2017 to 2023.

Americas’ clout in the global market is boosted by the growing cases of diabetes, a well-developed healthcare IT sector, high spending on healthcare, and the strong presence of renowned firms. The prevalence of diabetes has increased due to the rising cases of obesity and sedentary lifestyle with lack of exercise and the active participation of leading companies, government agencies and private organization in this regard has fostered the market growth in the region.

Europe has been the second highest gainer in the global market on account of the increasing support from the government in terms of research & development coupled with the burgeoning geriatric populace in the region. The vast improvement in every aspect of the healthcare industry and the rising deployment of superior quality medical products has also augmented the market demand in Europe to a large extent.

With the fastest growth, the APAC market will emerge to be highly lucrative for the top players. Market attractiveness in the region will be the result of the ongoing advancements in healthcare facilities along with the surge in reimbursement policies in India and Japan. China is however, the market leader in the region thanks to the expansive diabetic population and the fast economic growth in the country. The increasing awareness with regard to diabetes preventive care also speeds up the market growth rate in the region.

Reputed Firms

Some of the most reputed vendors in the global market for diabetes monitors include Dexcom, Inc., LifeScan, Inc., Sanofi, Panasonic, Abbott Laboratories, Medtronic, F. Hoffmann-La Roche Ltd, to name a few.

Industry Analysis Reports | Health Care | Medical Devices | Pharmaceutical

Labels

Thursday 29 October 2020

Retinal Implants Market 2018 – Leading Manufactures, Regions, Drivers, Analysis and Forecasts Till 2025

Spirometry market News, Trends, Demand and Forecast

News: Type 2 diabetes mellitus treatment market 2020 | Trends | Analysis - MRFR

Veterinary Pain Management Market -Size, share, 2020, Global Demand by 2027

Wednesday 28 October 2020

Trends On Neurovascular Devices Market (2020-2023) | Size | Share | Key Trends and Forecast

News: Healthcare CMO Market 2020 -Demand, Size, Share and Research, Global Demand by 2023

Diabetes Monitors Market Investigation by Application, Technology and Product Type

Blog Archive

Total Pageviews